Imininingwane Esheshayo
Ngokusekelwe kumgomo wokubopha ngokuncintisana
Gcina njengoba kupakishwe esikhwameni esivaliwe ezingeni lokushisa (4-30℃ noma 40-86℉)
I-Lateral flow chromatographic immunoassay
Ukupakisha Nokulethwa
| Imininingwane yokupakisha:Iphakheji yokuthekelisa ejwayelekile Imininingwane yokulethwa: phakathi nezinsuku zokusebenza eziyi-7-10 ngemuva kokuthola inkokhelo |
Imininingwane
Ikhithi yokuhlola esheshayo ye-Quality discovery AMRDT110
Ikhithi yokuhlola esheshayo ye-AMRDT110 iyi-lateral flow chromatographic immunoassay ukuze kutholwe ikhwalithi yezidakamizwa eziningi kanye nama-metabolite ezidakamizwa emchameni kulokhu kugxila okulandelayo:
| Isivivinyo | I-Calibrator | Ukusika (ng/mL) |
| I-Amphetamine (AMP1000) | I-D-Amphetamine | 1,000 |
| I-Amphetamine (AMP500) | I-D-Amphetamine | 500 |
| I-Amphetamine (AMP300) | I-D-Amphetamine | 300 |
| I-Benzodiazepines (BZO300) | I-Oxazepam | 300 |
| I-Benzodiazepines (BZO200) | I-Oxazepam | 200 |
| Ama-Barbiturates (BAR) | I-Secobarbital | 300 |
| I-Buprenorphine (BUP) | I-Buprenorphine | 10 |
| I-Cocaine (COC) | I-Benzoylecgonine | 300 |
| I-Cotinine (COT) | I-Cotinine | 200 |
| I-Methadone metabolite (EDDP) | 2-Ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine | 100 |
| I-Fentanyl (FYL) | I-Fentanyl | 200 |
| I-Ketamine (KET) | I-Ketamine | 1,000 |
| I-Synthetic Cannabinoid (K2 50) | JWH-018 5-pentanoic acid/ JWH-073 4-Butanoic acid | 50 |
| I-Synthetic Cannabinoid (K2 200) | JWH-018 5-pentanoic acid/ JWH-073 4-Butanoic acid | 200 |
| I-Methamphetamine (mAMP1000/ MET1000) | I-D-Methamphetamine | 1,000 |
| I-Methamphetamine (mAMP500/ MET500) | I-D-Methamphetamine | 500 |
| I-Methamphetamine (mAMP300/ MET300) | I-D-Methamphetamine | 300 |
| I-Methylenedioxymethamphetamine (MDMA) | D,L-Methylenedioxymethamphetamine | 500 |
| I-Morphine (MOP300/ OPI300) | I-Morphine | 300 |
| I-Methadone (MTD) | I-Methadone | 300 |
| I-Methaqualone (MQL) | I-Methaqualone | 300 |
| Ama-opiates (OPI 2000) | I-Morphine | 2,000 |
| I-Oxycodone (OXY) | I-Oxycodone | 100 |
| I-Phencyclidine (PCP) | I-Phencyclidine | 25 |
| I-Propoxyphene (PPX) | I-Propoxyphene | 300 |
| I-Tricyclic Antidepressants (TCA) | I-Notriptyline | 1,000 |
| Insangu (THC) | 11-nor-Δ9-THC-9-COOH | 50 |
| I-Tramadol (TRA) | I-Tramadol | 200 |
Ukulungiselelwa kwekhithi yokuhlola esheshayo ye-Qualitative discovery AMRDT110 ingaqukatha noma iyiphi inhlanganisela yabahlaziyi bezidakamizwa abasohlwini olungenhla.
[ISIMISO]
I-Qualitative discovery test ngokushesha i-AMRDT110 iwukuhlolwa kokuzivikela komzimba okususelwe kumgomo wokubopha okuncintisanayo.Izidakamizwa okungenzeka zibe khona esibonelweni somchamo ziqhudelana nenhlanganisela yazo yezidakamizwa ukuze zibophe amasayithi ku-antibody yazo ethile.
Ngesikhathi sokuhlolwa, isampula yomchamo ihambela phezulu ngesenzo se-capillary.Umuthi, uma ukhona esifanekisweni somchamo ngaphansi kokugxila kwawo esikiwe, ngeke ugcwalise amasayithi okubopha ama-antibody awo athile.I-antibody izobe isisabela nge-conjugate ye-drug-protein futhi ulayini onombala obonakalayo uzovela esifundeni somugqa wokuhlola womugqa othile womuthi.Ukuba khona komuthi ngaphezu kokugxiliswa okunqunyiwe kuzogcwalisa zonke izingosi ezibophayo ze-antibody.Ngakho-ke, umugqa onemibala ngeke wakhe endaweni yomugqa wokuhlola.
Isampula somchamo onomuthi ngeke sikhiqize umugqa onemibala endaweni ethile yokuhlola yomugqa ngenxa yokuncintisana kwezidakamizwa, kuyilapho isifanekiso somchamo ongenawo umuthi sizokhiqiza umugqa endaweni yokuhlola ngenxa yokungabikho kokuncintisana kwezidakamizwa.
Ukuze usebenze njengokulawula kwenqubo, ulayini onemibala uzohlala uvela endaweni yomugqa wokulawula, okubonisa ukuthi umthamo ofanele we-specimen ungeziwe futhi i-membrane wicking yenzekile.
